Search research articles
Contact Us
Filters
Showing results (721-730 of 792) with videos related to
Page
of 80
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma
Liz Y Han, Mavis S Fletcher, Diana L Urbauer, et al.
Journal of the National Cancer Institute
|
January 10, 2008
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver
Michael J Gray, George Van Buren, Nikolaos A Dallas, et al.
Psychiatric Genetics
|
August 13, 2009
Long tandem repeats as a form of genomic copy number variation: structure and length polymorphism of a chromosome 5p repeat in control and schizophrenia populations
Heather A Bruce, Nancy Sachs, Dobrila D Rudnicki, et al.
Cancer Biology & Therapy
|
December 17, 2009
Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models
Chunhua Lu, Mian M K Shahzad, Myrthala Moreno-Smith, et al.
Clinical Immunology (Orlando, Fla.)
|
September 12, 2015
Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C
Diane M Da Silva, Andrew W Woodham, Joseph G Skeate, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 10, 2024
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)
Ritu Salani, Mary McCormack, Yong-Man Kim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)
Ritu Salani, Mary McCormack, Yong-Man Kim, et al.
ESMO Open
|
June 5, 2026
Furmonertinib-based triplet therapy improves survival in EGFR-mutant NSCLC with leptomeningeal metastases: a large-scale multicenter retrospective study (FURMO-LM)
H Chen, H Xu, Z Yin, et al.
International Journal of Cancer
|
December 6, 2008
Functional significance of VEGFR-2 on ovarian cancer cells
Whitney A Spannuth, Alpa M Nick, Nicholas B Jennings, et al.
Journal of the National Cancer Institute
|
March 4, 2008
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth
William M Merritt, Yvonne G Lin, Whitney A Spannuth, et al.
Page
of 80
Search research articles
Search
Showing results (721-730 of 792) with videos related to
Sort By:
Page
of 80
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma
Liz Y Han, Mavis S Fletcher, Diana L Urbauer, et al.
Journal of the National Cancer Institute
|
January 10, 2008
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver
Michael J Gray, George Van Buren, Nikolaos A Dallas, et al.
Psychiatric Genetics
|
August 13, 2009
Long tandem repeats as a form of genomic copy number variation: structure and length polymorphism of a chromosome 5p repeat in control and schizophrenia populations
Heather A Bruce, Nancy Sachs, Dobrila D Rudnicki, et al.
Cancer Biology & Therapy
|
December 17, 2009
Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models
Chunhua Lu, Mian M K Shahzad, Myrthala Moreno-Smith, et al.
Clinical Immunology (Orlando, Fla.)
|
September 12, 2015
Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C
Diane M Da Silva, Andrew W Woodham, Joseph G Skeate, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 10, 2024
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)
Ritu Salani, Mary McCormack, Yong-Man Kim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)
Ritu Salani, Mary McCormack, Yong-Man Kim, et al.
ESMO Open
|
June 5, 2026
Furmonertinib-based triplet therapy improves survival in EGFR-mutant NSCLC with leptomeningeal metastases: a large-scale multicenter retrospective study (FURMO-LM)
H Chen, H Xu, Z Yin, et al.
International Journal of Cancer
|
December 6, 2008
Functional significance of VEGFR-2 on ovarian cancer cells
Whitney A Spannuth, Alpa M Nick, Nicholas B Jennings, et al.
Journal of the National Cancer Institute
|
March 4, 2008
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth
William M Merritt, Yvonne G Lin, Whitney A Spannuth, et al.
Page
of 80